News 2024-12-06
Porton is thrilled to announce the launch of its newly redesigned official website
With a Focus on Globalization, Innovative Technology Platforms, and
Accelerating Your New Business Opportunities into the Clinic and to the Market.
The newly revamped website strategically highlights our commitment to a global service model, offering an enhanced customer experience through renewed and upgraded website features. This digital transformation aligns with Porton's mission of enabling the public’s early access to good medicines and underscores our dedication to providing comprehensive and innovative CDMO services. The redesigned site offers deep insights into Porton’s expanded range of Drug Substance and Drug Product services and innovative solutions, reinforcing Porton’s commitment to excellence and customer-centric focus on our global clientele.
The upgraded website, accessible at www.portonpharma.com, boasts a modern design and intuitive layout, making it easier for visitors to explore Porton’s portfolio of service offerings, site profiles, and technical solutions. We would like to discuss the key features of the new site with you.
Enhanced Navigation
A responsive and business driven design that provides seamless access across all devices, allowing users to find information quickly and efficiently.
This newly launched website embodies Porton's global vision and strategy, enabling users from all over the world to easily explore our new capabilities and services. This step towards a more international presence allows us to connect more effectively with our global clientele and partners.
Connect with Us and Accessing Insightful Resources
Porton's website now offers a library of practical case studies, whitepapers, newsletter and industry insights to invite collaboration with our customers, and illustrating how we overcome technical challenges with our advanced technological solutions. Engage with us to understand how we can cater to your specific needs and project requirements.
We warmly invite you to explore the innovative changes on www.portonpharma.com,
and discover how our new reach and fresh content can empower your business to
achieve new heights.
Others
More
News 2025-03-21
Porton's Near-Term Target Validated by the SBTi
March 20, 2025, Chongqing—Porton Pharma Solutions Ltd. (Porton) announced today that its near-term greenhouse gas emissions reductions targets have been formally validated by the Science Based Targets initiative (SBTi). This milestone not only signifies its strategic breakthrough in climate governance, but also demonstrates that its decarbonization roadmap is aligned with the 1.5°C climate mitigation pathway.
News 2025-03-19
Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T Cell Therapy Development
Cranbury, New Jersey, March 19, 2025 — Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Eureka Therapeutics, Inc., a clinical-stage biotechnology company dedicated to developing novel T‑cell therapies for both solid tumors and hematologic malignancies.
